Lipids: new guidelines, intensive treatment, and future directions.
Jones
Peter H
PH
Lipid Metabolism and Atherosclerosis Clinic, and Methodist Wellness Center for Weight Management, Houston, Texas 77030, USA. jones@bcm.tmc.edu
D015897:Comorbidity; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008055:Lipids; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D010316:Particle Size; D017410:Practice Guidelines as Topic; D019821:Simvastatin / Q000494:pharmacology / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D019821:Simvastatin